- Home
- PLUG vs ADMA Comparison
PLUG vs ADMA Comparison
Compare PLUG & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- ADMA
- Stock Information
- Founded
- PLUG 1997
- ADMA 2004
- Country
- PLUG United States
- ADMA United States
- Employees
- PLUG N/A
- ADMA N/A
- Industry
- PLUG Industrial Machinery/Components
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLUG Energy
- ADMA Health Care
- Exchange
- PLUG Nasdaq
- ADMA Nasdaq
- Market Cap
- PLUG 3.1B
- ADMA 3.5B
- IPO Year
- PLUG 1999
- ADMA N/A
- Fundamental
- Price
- PLUG $2.75
- ADMA $15.31
- Analyst Decision
- PLUG Hold
- ADMA Strong Buy
- Analyst Count
- PLUG 16
- ADMA 3
- Target Price
- PLUG $2.29
- ADMA $27.67
- AVG Volume (30 Days)
- PLUG 130.2M
- ADMA 3.4M
- Earning Date
- PLUG 11-07-2025
- ADMA 11-05-2025
- Dividend Yield
- PLUG N/A
- ADMA N/A
- EPS Growth
- PLUG N/A
- ADMA 469.09
- EPS
- PLUG N/A
- ADMA 0.85
- Revenue
- PLUG $672,844,000.00
- ADMA $474,174,000.00
- Revenue This Year
- PLUG $21.18
- ADMA $21.08
- Revenue Next Year
- PLUG $26.00
- ADMA $25.98
- P/E Ratio
- PLUG N/A
- ADMA $18.18
- Revenue Growth
- PLUG N/A
- ADMA 43.58
- 52 Week Low
- PLUG $0.69
- ADMA $13.50
- 52 Week High
- PLUG $4.58
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- PLUG 45.61
- ADMA 50.39
- Support Level
- PLUG $2.56
- ADMA $15.07
- Resistance Level
- PLUG $3.05
- ADMA $15.76
- Average True Range (ATR)
- PLUG 0.30
- ADMA 0.56
- MACD
- PLUG -0.13
- ADMA 0.13
- Stochastic Oscillator
- PLUG 11.24
- ADMA 56.46
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.